CLDX Insider Trading

Insider Ownership Percentage: 3.80%
Insider Buying (Last 12 Months): $308,430.00
Insider Selling (Last 12 Months): $9,155,821.33

Celldex Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Celldex Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$5M$0$5MTotal Insider BuyingTotal Insider Selling

Celldex Therapeutics Share Price & Price History

Current Price: $19.93
Price Change: Price Decrease of -0.05 (-0.25%)
As of 03/28/2025 05:00 PM ET

This chart shows the closing price history over time for CLDX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$19.93Closing price on 03/29/25:

SEC Filings (Institutional Ownership Changes) for Celldex Therapeutics (NASDAQ:CLDX)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CLDX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$121Mbought$82MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$100M-$50M$0$50M$100MTotal InflowsTotal Outflows
Celldex Therapeutics logo
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.
Read More on Celldex Therapeutics

Today's Range

Now: $19.93
Low: $19.51
High: $20.19

50 Day Range

MA: $21.90
Low: $19.35
High: $25.51

52 Week Range

Now: $19.93
Low: $18.61
High: $47.00

Volume

673,963 shs

Average Volume

863,800 shs

Market Capitalization

$1.32 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.76

Who are the company insiders with the largest holdings of Celldex Therapeutics?

Celldex Therapeutics' top insider investors include:
  1. Anthony S Marucci (CEO)
  2. Samuel Bates Martin (CFO)
  3. Richard M Wright (VP)
  4. Elizabeth Crowley (VP)
  5. Margo Heath-Chiozzi (SVP)
  6. Diane C Young (SVP)
Learn More about top insider investors at Celldex Therapeutics.

Who are the major institutional investors of Celldex Therapeutics?

Celldex Therapeutics' top institutional investors include:
  1. Wellington Management Group LLP — 13.52%
  2. FMR LLC — 7.32%
  3. Vanguard Group Inc. — 5.85%
  4. Price T Rowe Associates Inc. MD — 5.36%
  5. Point72 Asset Management L.P. — 3.79%
  6. Woodline Partners LP — 3.04%
Learn More about top institutional investors of Celldex Therapeutics stock.

Which institutional investors are selling Celldex Therapeutics stock?

During the previous quarter, CLDX stock was sold by these institutional investors:
  1. FMR LLC
  2. Polar Capital Holdings Plc
  3. Woodline Partners LP
  4. D. E. Shaw & Co. Inc.
  5. Wellington Management Group LLP
  6. Bank of America Corp DE
  7. Affinity Asset Advisors LLC
  8. Twinbeech Capital LP
During the previous year, company insiders that have sold Celldex Therapeutics company stock include:
  1. Anthony S Marucci (CEO)
  2. Samuel Bates Martin (CFO)
  3. Richard M Wright (VP)
  4. Elizabeth Crowley (VP)
  5. Margo Heath-Chiozzi (SVP)
Learn More investors selling Celldex Therapeutics stock.

Which institutional investors are buying Celldex Therapeutics stock?

During the previous quarter, CLDX stock was purchased by institutional investors including:
  1. Deep Track Capital LP
  2. Point72 Asset Management L.P.
  3. Price T Rowe Associates Inc. MD
  4. Vestal Point Capital LP
  5. American Century Companies Inc.
  6. TFG Asset Management GP Ltd
  7. TFG Asset Management GP Ltd
  8. Crestline Management LP